| FXAIX | LAMHX | FXAIX / LAMHX | |
| Total Expense Ratio | 0.01 | 0.59 | 3% |
| Annual Report Gross Expense Ratio | 0.01 | 0.59 | 3% |
| Fund Existence | 15 years | 11 years | - |
| Gain YTD | 1.998 | 2.504 | 80% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 753B | 4.82B | 15,632% |
| Annual Yield % from dividends | 1.10 | 0.84 | 131% |
| Returns for 1 year | 17.83 | 12.15 | 147% |
| Returns for 3 years | 75.94 | 51.11 | 149% |
| Returns for 5 years | 93.74 | 49.40 | 190% |
| Returns for 10 years | 310.97 | 125.22 | 248% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| UAPSX | 66.79 | 0.38 | +0.57% |
| ProFunds UltraSmall Cap Svc | |||
| VGREX | 7.25 | 0.03 | +0.42% |
| VALIC Company I Global Real Estate | |||
| PLVJX | 17.47 | 0.03 | +0.17% |
| Principal Large Cap Value III J | |||
| PASTX | 59.56 | -0.44 | -0.73% |
| T. Rowe Price Science & Tech Adv | |||
| EIHSX | 13.75 | -0.18 | -1.29% |
| Eaton Vance Worldwide Health Sci I | |||